Norman Fost
-
- Ethics and Legal Issues in Pediatric Healthcare 38
- Childhood Cancer Survivors' Quality of Life 9
-
- Ethics in Clinical Research 16
- Organ Donation and Transplantation 12
- Palliative Care and End-of-Life Issues 9
- Pharmacy top 2%
- General Health Professions top 2%
- Ethics in medical practice 18
- Clinical Biochemistry top 5%
-
- BRCA gene mutations in cancer 10
-
- Cystic Fibrosis Research Advances 10
- Co-authors
- Nancy B. EsterlyMichael J. GreenDavid B. AllenBenjamin S. WilfondPhilip M. FarrellAideen McInerney‐LeoBarbara B. BieseckerElaine H. Mischler
- Cited by
- Pediatrics, Perinatology and Child HealthPublic Health, Environmental and Occupational HealthPharmacy
- Partner nations
- United StatesVietnamUnited Kingdom
In The Last Decade
Norman Fost
103 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 137
- Pediatrics, Perinatology and Child Health 745
- Public Health, Environmental and Occupational Health 716
- Pharmacy 107
- General Health Professions 538
- Clinical Biochemistry 121
Countries citing papers authored by Norman Fost
This map shows the geographic impact of Norman Fost's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norman Fost with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norman Fost more than expected).
Fields of papers citing papers by Norman Fost
This network shows the impact of papers produced by Norman Fost. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norman Fost. The network helps show where Norman Fost may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Norman Fost, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 10 | |
| 2 | 2017 | 3 | |
| 3 | 2016 | 7 | |
| 4 | 2013 | 53 | |
| 5 | 2011 | 38 | |
| 6 | 2005 | 26 | |
| 7 | 2004 | 45 | |
| 8 | 2004 | 2 | |
| 9 | Ethical issues in growth hormone therapy: Where are we now? University of Wisconsin Children's Hospital - Madison, October 9-11, 1999 | 2001 | 2 |
| 10 | Is the treatment/enhancement distinction useful? | 2001 | 2 |
| 11 | 2001 | 21 | |
| 12 | 2001 | 110 | |
| 13 | 2001 | 12 | |
| 14 | 1997 | 25 | |
| 15 | 1993 | 15 | |
| 16 | 1992 | 26 | |
| 17 | Sterilization of women who are mentally handicapped | 1990 | 14 |
| 18 | 1990 | 3 | |
| 19 | 1989 | 10 | |
| 20 | 1968 | 194 |
About Norman Fost
Norman Fost is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health and General Health Professions, having authored 106 papers that have together received 2.5k indexed citations. Recurring topics across this work include Ethics and Legal Issues in Pediatric Healthcare (38 papers), Ethics in medical practice (18 papers), Ethics in Clinical Research (16 papers), Organ Donation and Transplantation (12 papers), BRCA gene mutations in cancer (10 papers), Cystic Fibrosis Research Advances (10 papers), Childhood Cancer Survivors' Quality of Life (9 papers) and Palliative Care and End-of-Life Issues (9 papers). The work is most often cited by research in Pediatrics, Perinatology and Child Health (745 citations), Public Health, Environmental and Occupational Health (716 citations) and Pharmacy (107 citations). Norman Fost has collaborated with scholars based in United States, Vietnam and United Kingdom. Frequent co-authors include Nancy B. Esterly, Michael J. Green, David B. Allen, Benjamin S. Wilfond, Philip M. Farrell, Aideen McInerney‐Leo, Barbara B. Biesecker, Elaine H. Mischler, Megan A. Moreno and Dimitri Christakis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.